A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs, thanks to the work ...

like BRCA mutations, to preferentially kill cancer cells. Olaparib is being jointly developed and commercialized by AstraZeneca and Merck. Currently the drug is being evaluated in Phase III for ...

Former Member of Parliament for Kumbungu, Ras Mubarak, has taken a swipe at veteran broadcaster Kwesi Pratt Jnr following the latter's frustrations against politically motivated appointments under ...

In the FIRE-3 randomized clinical trial he led in 2020, it was found that among patients with left-sided tumors, folinic acid, 5-fluorouracil, and irinotecan (FOLFIRI) combined with cetuximab ...

RAS is the most frequently mutated oncogene in cancer, with KRAS mutations occurring in nearly one-quarter of all human cancers. RAS mutations impair the ability of RAS to convert from its active ...

RAS is the most frequently mutated oncogene in cancer, with KRAS mutations occurring in nearly one-quarter of all human cancers. RAS mutations impair the ability of RAS to convert from its active ...

With two rounds of the NCAA tournament down, there are still plenty of NBA prospects advancing to the Sweet 16. A number of big names have also been sent home early. Scouts remain very curious ...

Selected Examples in Personalized Medicine in Cancer, CoDxs & Challenges in the Field The term 'companion biomarker' sometimes is used in the field of personalized medicine for biomarker-based ...